References
- Huang J, Barbera L, Brouwers M, et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003;21:555–563
- Bellon JR, Come SE, Gelman RS, et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol 2005;23:1934–1940
- Sartor CI, Peterson BL, Woolf S, et al. Effect of addition of adjuvant paclitaxel on radiotherapy delivery and loco-regional control of node-positive breast cancer: cancer and leukemia group B 9344. J Clin Oncol 2005;23:30–40
- Rouesse J, de la Lande B, Bertheault-Cvitkovic F, et al. A phase III randomized trial comparing adjuvant con-comitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: Final results. Int J Radiat Oncol Biol Phys 2006;64:1072–1080
- Bellon JR, Shulman LN, Come SE, et al. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluoro-uracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma. Cancer 2004;100:1358–1364
- Calais G, Serin D, Fourquet A. Randomized study com-paring adjuvant radiotherapy with concomitant chemo-therapy versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma: long term results. Proceedings of the 47th Annual ASTRO Meeting. Denver, CO 2005
- Haffty BG, Kim JH, Yang Q, et al. Concurrent Chemo-Radiation in the Conservative Management of Breast Cancer. Int J Radiation Oncol Biol Phys 2006; in press
- Burstein HJ, BelIon JR, Galper S, et al. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemo-therapy for Stage II or III breast cancer. Int J Radiat Oncol Biol Phys 2006;64:496–504